Phase II Study of Modified Triple Doublet Therapy in Women With Newly Diagnosed Mullerian Carcinoma

NCT00157560 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

83

Enrollment

OTHER

Sponsor class

Conditions

Ovarian Cancer
Fallopian Tube Cancer
Primary Peritoneal Cancer

Interventions

DRUG: Chemotherapy, multiple agents

Sponsor

Massachusetts General Hospital

Collaborators

[object Object]
[object Object]